Last reviewed · How we verify
Treatment of Mild Vascular Cognitive Impairment With Yangxue Qingnao Pill
In this study, the effectiveness of vascular cognitive impairment was compared among the three groups, namely, the xidezhen group, the Yangxue Qingnao pill group and the placebo group
Details
| Lead sponsor | Peking University Third Hospital |
|---|---|
| Phase | NA |
| Status | COMPLETED |
| Enrolment | 60 |
| Start date | Wed Aug 30 2017 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Sat Mar 31 2018 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Cerebrovascular Diseases
Interventions
- Yangxue Qingnao pill
- Hydergotoxine mesylate tablets
- blank control group
Countries
China